Nagashima, S., Wakabayashi, T., Saito, N., Takahashi, M., Okada, K., Ebihara, K., & Ishibashi, S. (2020). Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome. J Diabetes Investig.

Nagashima, Shuichi, Tetsuji Wakabayashi, Naoko Saito, Manabu Takahashi, Kenta Okada, Ken Ebihara, a Shun Ishibashi. "Long‐term Efficacy of the Sodium–glucose Cotransporter 2 Inhibitor, Ipragliflozin, in a Case of Type A Insulin Resistance Syndrome." J Diabetes Investig 2020.

Nagashima, Shuichi, et al. "Long‐term Efficacy of the Sodium–glucose Cotransporter 2 Inhibitor, Ipragliflozin, in a Case of Type A Insulin Resistance Syndrome." J Diabetes Investig 2020.